Wells Fargo analyst Roger Read initiated coverage of Marathon Oil with an Overweight rating and $41 price target, identifying it as a "top pick for the sector" given its execution, inventory, cash returns and share repurchases. The firm, which estimates Marathon will have retired 20% of its outstanding common shares compared with pre-pandemic levels by the end of Q1, notes that its 2023 EPS estimate is 10% above the current consensus forecast.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on MRO:
- Marathon Oil Corporation Declares Fourth Quarter 2022 Dividend
- Marathon Oil upgraded to Overweight from Equal Weight at Morgan Stanley
- Marathon Oil price target lowered to $30 from $31 at Citi
- Marathon Oil price target lowered to $40 from $42 at Piper Sandler
- Marathon Oil assumed with Neutral from Buy at Mizuho